Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Read More 5 minute read Pharma Industry News What the LYMPHIR–pembrolizumab combination signals for the future of immunotherapy resistance (NASDAQ: CTOR) Citius Oncology reports LYMPHIR immunotherapy data in gynecologic cancers. Discover what the trial signals for the future of cancer immunotherapy. bySoujanya RaviMarch 13, 2026